Clarity expands its pipeline with a novel optimised FAP-targeted radiopharmaceutical
Highlights Clarity has developed a proprietary fibroblast activation protein (FAP)-targeted radiopharmaceutical product that can be used with the perfect pairing of copper isotopes for the diagnosis and treatment of cancer. The product, termed...
Umbra Selected for NRO's Strategic Commercial Enhancements Stage III, Strengthening U.S. SAR Capabilities
WASHINGTON, Dec. 4, 2024 /PRNewswire/ -- Umbra, a vertically integrated space technology company operating the world's highest-resolution commercial Synthetic Aperture Radar (SAR) satellites, has been awarded the Stage III option of the National...